Won Young Tak

Kyungpook National University Hospital — South Korea

Medicine · Health Sciences

55h-index20.8kcitations382works29.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(147), Hepatocellular Carcinoma Treatment and Prognosis(100), Hepatitis B Virus Studies(91), Hepatitis C virus research(88), Liver Disease and Transplantation(47)

Publications377 total

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Nature Medicine·2025· 2 citedOpen Access
Analysis of 3D Distribution Maps of Body Composition Using 3D Abdominal Computed Tomography and Its Clinical Applications
Convergence Hepatology·2025Open Access
Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
Journal of Gastroenterology and Hepatology·2025· 2 citedOpen Access
Inter-Slice Dual Cross Attention and Class-Level Alignment for 2.5D Medical Image Segmentation
2025· 1 cited
A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma
Cancer Communications·2025· 1 citedOpen Access
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial
Hepatology·2025· 8 citedOpen Access
LBP-016 Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study
Journal of Hepatology·2025· 3 cited
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
Infectious Diseases and Therapy·2025Open Access
Efficient Medical Image Segmentation Using Probabilistic KNN Label Downsampling
2025Open Access
ISVAM : Interslice Variation Attention Module for 2.5D Multi-Organ Segmentation in CT
2025
Edge-Preserving Probabilistic Downsampling for Reliable Medical Segmentation in Resource-Constrained Environments
IEEE Access·2025Open Access
Unsupervised domain adaptation by cross-domain consistency learning for CT body composition
Machine Vision and Applications·2025· 3 citedOpen Access
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
The Lancet·2025· 153 citedOpen Access
Aspartate aminotransferase‐to‐platelet ratio index outperforms Fibrosis‐4 in 2843 Korean patients with metabolic dysfunction‐associated steatotic liver disease
Hepatology Research·2024· 3 citedOpen Access
Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Diagnostics·2024· 2 citedOpen Access
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
˜The œLancet. Gastroenterology & hepatology·2024· 54 citedOpen Access
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification
Scientific Reports·2024· 10 citedOpen Access
mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma
International Journal of Radiation Oncology*Biology*Physics·2024· 1 cited
Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria
Scientific Reports·2024· 2 citedOpen Access
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
Journal of Hepatology·2024· 30 cited
page 1 of 19Next →

Frequent Co-authors

Soo Young Park(17), Young Oh Kweon(15), Masatoshi Kudo(12), Jeong Heo(11), Kwang‐Hyub Han(10), Seong Woo Jeon(9), Min Kyu Jung(8), Chang Min Cho(8), Shukui Qin(7), Jordi Bruix(7), Josep M. Llovet(6), Riccardo Lencioni(6), Hyung Joon Yim(6), Young Seok Kim(6), Sung Kook Kim(6), In Hee Kim(6), Ann‐Lii Cheng(5), Gerold Meinhardt(5), Thomas Decaens(5), Do Young Kim(5)